Year |
Citation |
Score |
2012 |
Runkle KB, Meyerkord CL, Desai NV, Takahashi Y, Wang HG. Bif-1 suppresses breast cancer cell migration by promoting EGFR endocytic degradation. Cancer Biology & Therapy. 13: 956-66. PMID 22785202 DOI: 10.4161/Cbt.20951 |
0.501 |
|
2012 |
Qi Q, He K, Liu X, Pham C, Meyerkord C, Fu H, Ye K. Disrupting the PIKE-A/Akt interaction inhibits glioblastoma cell survival, migration, invasion and colony formation. Oncogene. 32: 1030-40. PMID 22450747 DOI: 10.1038/Onc.2012.109 |
0.439 |
|
2011 |
Zhao J, Meyerkord CL, Du Y, Khuri FR, Fu H. 14-3-3 proteins as potential therapeutic targets. Seminars in Cell & Developmental Biology. 22: 705-12. PMID 21983031 DOI: 10.1016/J.Semcdb.2011.09.012 |
0.352 |
|
2011 |
Takahashi Y, Meyerkord CL, Hori T, Runkle K, Fox TE, Kester M, Loughran TP, Wang HG. Bif-1 regulates Atg9 trafficking by mediating the fission of Golgi membranes during autophagy. Autophagy. 7: 61-73. PMID 21068542 DOI: 10.4161/Auto.7.1.14015 |
0.641 |
|
2010 |
Takahashi Y, Meyerkord CL, Gonsar K, Hori T, Wang H. Abstract 4835: Bif-1 induces the fission of Golgi membranes to generate Atg9-containing vesicles for autophagosome formation Cancer Research. 70: 4835-4835. DOI: 10.1158/1538-7445.Am10-4835 |
0.62 |
|
2009 |
Takahashi Y, Meyerkord CL, Wang HG. Bif-1/endophilin B1: a candidate for crescent driving force in autophagy. Cell Death and Differentiation. 16: 947-55. PMID 19265852 DOI: 10.1038/Cdd.2009.19 |
0.619 |
|
2008 |
Meyerkord CL, Takahashi Y, Araya R, Takada N, Weiss RS, Wang HG. Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins. Oncogene. 27: 7248-59. PMID 18794804 DOI: 10.1038/onc.2008.336 |
0.518 |
|
2008 |
Takahashi Y, Meyerkord CL, Wang HG. BARgaining membranes for autophagosome formation: Regulation of autophagy and tumorigenesis by Bif-1/Endophilin B1. Autophagy. 4: 121-4. PMID 18032918 DOI: 10.4161/Auto.5265 |
0.632 |
|
2005 |
Araya R, Hirai I, Meyerkord CL, Wang HG. Loss of RPA1 induces Chk2 phosphorylation through a caffeine-sensitive pathway. Febs Letters. 579: 157-61. PMID 15620706 DOI: 10.1016/J.Febslet.2004.11.066 |
0.511 |
|
Show low-probability matches. |